Next Financial Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1K Hold
7
﹤0.01% 2809
2021
Q3
$1K Hold
7
﹤0.01% 2687
2021
Q2
$1K Hold
7
﹤0.01% 2568
2021
Q1
$1K Buy
7
+4
+133% +$372 ﹤0.01% 2467
2020
Q4
$0 Buy
+3
New +$309 ﹤0.01% 2417
2016
Q1
Sell
-10
Closed -$1K 1861
2015
Q4
$1K Sell
10
-20
-67% -$1.98K ﹤0.01% 1719
2015
Q3
$2K Hold
30
﹤0.01% 1643
2015
Q2
$3K Buy
30
+20
+200% +$2.49K ﹤0.01% 1619
2015
Q1
$1K Buy
+10
New +$1.3K ﹤0.01% 1798

Other funds holding TNDM

Next Financial Group's TNDM Position: Q4 2021 in Review

Next Financial Group held its Tandem Diabetes Care (TNDM) position steady in Q4 2021 at 7 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Next Financial Group first reported a position in TNDM in Q1 2015 and has held it in 9 quarters since. The position peaked at $3K in Q2 2015. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

  • Next Financial Group held 7 shares of Tandem Diabetes Care worth $1K as of Q4 2021.
  • Next Financial Group left its Tandem Diabetes Care share count unchanged in Q4 2021.
  • Tandem Diabetes Care made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2809 holding.
  • Next Financial Group first reported a position in Tandem Diabetes Care in Q1 2015 and has held it in 9 quarters since.
  • Next Financial Group's Tandem Diabetes Care position peaked at $3K in Q2 2015.
  • 388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.